Evidence map›Paper›PMID 34163218›Full record

ArticleInternational journal of general medicine2021

Clinical Characteristics of Lipid Metabolism in Untreated Patients with Anti-MDA5 Antibody-Positive.

Wenhan Huang, Feifeng Ren, Lei Luo, Jun Zhou, Dongmei Huang, Lin Tang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Wenhan HuangDepartment of Rheumatology and Immunology of the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Feifeng RenDepartment of Rheumatology and Immunology of the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Lei LuoDepartment of Rheumatology and Immunology of the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Jun ZhouDepartment of Rheumatology and Immunology of the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Dongmei HuangDepartment of Rheumatology and Immunology of the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Lin TangDepartment of Rheumatology and Immunology of the Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
Second Affiliated Hospital of Chongqing Medical University · CNChongqing Medical University · CNDalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveClinical characterization of lipid metabolism in untreated patients with anti-melanoma differentiation-associated gene 5 antibodies-positive (anti-MDA5

methodsBody-mass index (BMI), autoantibodies, lipid levels, and serum ferritin levels in 57 anti-MDA5

resultsPlasma high-density lipoprotein (HDL) and apolipoprotein A1 (ApoA1) levels were significantly lower in deceased group than in the survival group (P < 0.05). Plasma levels of HDL and ApoA1 were significantly lower in patients who were simultaneously anti-MDA5

conclusion1) HDL and ApoA1 levels are important indicators of poor prognosis in anti-MDA5

Indexed as

anti-melanoma differentiation-associated gene 5 antibodiesanti-Ro-52 antibodyapolipoprotein A1high-density lipoproteinlipid

Identifiers

PMID34163218
PMCPMC8214207
OpenAlexW3165924122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.